Live Breaking News & Updates on Ontra Synapse|Page 7

Stay updated with breaking news from Ontra synapse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jonathan Sheena Sells 5,000 Shares of Natera, Inc. (NASDAQ:NTRA) Stock

Natera, Inc. (NASDAQ:NTRA – Get Free Report) insider Jonathan Sheena sold 5,000 shares of Natera stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $60.30, for a total value of $301,500.00. Following the completion of the transaction, the insider now directly owns 469,743 shares in the company, […] ....

Jonathan Sheena , Natera Inc , Goldman Sachs Group , Morgan Stanley , Wolfe Research , Vanguard Group Inc , Jpmorgan Chase Co , Get Free Report , Street Corp , Kynam Capital Management , Capital Management , Natera Daily , Nasdaq Ntra , Insider Trading , Nsider Trades ,

Natera (NASDAQ:NTRA) PT Raised to $85.00

Natera (NASDAQ:NTRA – Free Report) had its price objective increased by BTIG Research from $75.00 to $85.00 in a research note published on Friday morning, Marketbeat.com reports. BTIG Research currently has a buy rating on the medical research company’s stock. Several other research firms have also recently weighed in on NTRA. StockNews.com initiated coverage on […] ....

Piper Sandler , Sanfordc Bernstein , Steven Leonard Chapman , Raymond James , Jonathan Sheena , Metlife Investment Management , Financial Services Group Inc , York Mellon Corp , Natera Company Profile , Natera Inc , Us Bancorp , Free Report , Moderate Buy , Get Free Report , Leonard Chapman , New York Mellon Corp , Services Group , Montreal Can , Natera Daily , Nasdaq Ntra , Boost Price Target , Btig Research ,

Natera (NASDAQ:NTRA) Price Target Raised to $64.00 at The Goldman Sachs Group

Natera (NASDAQ:NTRA – Free Report) had its price objective lifted by The Goldman Sachs Group from $56.00 to $64.00 in a research note released on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. A number of other equities analysts have also recently issued reports on NTRA. […] ....

James Healy , Piper Sandler , Wolfe Research , Natera Company Profile , Harbor Capital Advisors Inc , Kayne Anderson Rudnick Investment Management , Harvest Fund Management Co , Natera Inc , Quent Capital , Goldman Sachs Group , Free Report , Moderate Buy , Get Free Report , Director Gail Boxer Marcus , Director James Healy , Anderson Rudnick Investment Management , Capital Advisors , Fund Management , Natera Daily , Nasdaq Ntra , Boost Price Target , The Goldman Sachs Group Inc ,